TVGN
Tevogen Bio Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$40.24M
P/E Ratio
—
EPS
$-6.44
Beta
0.10
52W High
$75.50
52W Low
$4.13
50-Day MA
$6.64
200-Day MA
$21.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-21.00M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -294.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-4.24 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 18.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.19M |
| Float | $1.08M |
| % Insiders | 74.41% |
| % Institutions | 3.62% |
Historical Volatility
HV 10-Day
241.27%
HV 20-Day
178.52%
HV 30-Day
165.34%
HV 60-Day
157.46%
HV Rank
100.0%
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026